Precision Biosensor, Inc. (KOSDAQ:335810)
2,670.00
+45.00 (1.71%)
At close: Jan 23, 2026
Precision Biosensor Company Description
Precision Biosensor, Inc. engages in the development, production, and sale of immune diagnostic kits in South Korea.
It offers Exdia TRF Plus, an immunodiagnosis POCT platform; and Exdia PT10 and Exdia PT10S, a clinical chemistry POCT platform.
The company was founded in 2009 and is headquartered in Daejeon, South Korea.
Precision Biosensor, Inc.
| Country | South Korea |
| Founded | 2009 |
| Industry | Measuring and Controlling Devices, not elsewhere classified |
| Employees | 98 |
| CEO | Han-Shin Kim |
Contact Details
Address: 306, Techno 2-ro Daejeon, 34036 South Korea | |
| Phone | 82 4 2867 6300 |
| Website | precision-bio.com |
Stock Details
| Ticker Symbol | 335810 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Han-Shin Kim | Chief Executive Officer |
| Seunghoon Lee | Chief Financial Officer |